Long-Read Sequencing Market Size, Share, Trends And Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Long-read Sequencing Market Size Analysis

Global Long-read Sequencing Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing
    1. By Value
  3. Nanopore Sequencing
    1. By Value
  4. Others
    1. By Value
3. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing
    1. By Value
  4. Metagenomics
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic & Research Institutes
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharmaceutical & Biotechnology Companies
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing
    1. By Value
  3. Nanopore Sequencing
    1. By Value
  4. Others
    1. By Value
3. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing
    1. By Value
  4. Metagenomics
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic & Research Institutes
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharmaceutical & Biotechnology Companies
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing
    1. By Value
  3. Nanopore Sequencing
    1. By Value
  4. Others
    1. By Value
3. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing
    1. By Value
  4. Metagenomics
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic & Research Institutes
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharmaceutical & Biotechnology Companies
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing
    1. By Value
  3. Nanopore Sequencing
    1. By Value
  4. Others
    1. By Value
3. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing
    1. By Value
  4. Metagenomics
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic & Research Institutes
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharmaceutical & Biotechnology Companies
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Single-Molecule Real-Time Sequencing
  1. By Value
3. Nanopore Sequencing
  1. By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing
  1. By Value
4. Metagenomics
  1. By Value
5. RNA Sequencing
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic & Research Institutes
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharmaceutical & Biotechnology Companies
  1. By Value
5. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Single-Molecule Real-Time Sequencing
    1. By Value
  3. Nanopore Sequencing
    1. By Value
  4. Others
    1. By Value
3. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing
    1. By Value
  4. Metagenomics
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic & Research Institutes
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharmaceutical & Biotechnology Companies
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Long-read Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Oxford Nanopore Technologies Limited
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Quantapore, Inc.
Agilent Technologies
Element Biosciences
BGI
Eurofins Genomics
Hoffmann-La Roche Ltd.
MicrobesNG
Takara Bio
New England Biolabs
Pacific Biosciences of California, Inc.
Target ALS
Athena Diagnostics
Volta Labs, Inc.
MGI Tech Co., Ltd.
Illumina, Inc.
Pacific Biosciences of California
Wasatch BioLabs
PacBio
Swiss Rockets AG

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment